Cancer Research Horizons (investor - Corporate Investor)

See something wrong or missing? Let us know

Offices:London

Cancer Research Horizons is a British specialist drug discovery, development and commercialisation company

Average round investment:11.2M USD

Average number per year:2.0

Distribution: 2024 (2)

Portfolio companies: United Kingdom

Mostly invests in:

United Kingdom (2) Manufacturing (2)

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.